HIV Treatment Bulletin - December 2003 / January 2004
Polly Clayden, HIV i-Base

In order to assess whether there is any evidence to support the widely held view that Africans living in the UK are less likely to accept and adhere to HAART, a small retrospective study from Newham General Hospital evaluated adherence levels and virological response in African vs non-African patients.

The investigators performed a case note review of all HIV positive persons diagnosed between October 1998 and October 2001, allowing a minimum follow up period of 15 months. Pregnant women or those diagnosed through antenatal testing and people who were antiretroviral experienced were excluded from the analysis.

Of a total of 142 eligible patients, 117 were African and 25 non-African. African patients were more likely to be women compared to non-Africans (58% vs 28%). They were also more likely to present with a lower CD4 count (197 vs 245 cells/mm³).

The investigators reported no difference in achieving undetectable viral load results of <50 copies/mL (one or more measurement during the study period) – 83% in both groups. At six and 18 months the proportion of patients with an undetectable viral load was 76% and 59% for African and 67% and 44% for non-African. They also reported that despite lower initial CD4 counts, African patients achieved similar increases in CD4 counts over time.

The investigators concluded that this study suggests in this London clinic: “The uptake and adherence in African patients is similar to non-African patients.”

Ref: Wheeler H, Leventis P, Chilton D et al. Do African patients accept and adhere to HAART? European AIDS Conf 2003 Oct 25-29;9:10.1/9 (Abstract no. 294)

031210
IB30410-08

©2003. I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7407 8488 F: +44 (0) 20 7407 8489

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.